Prevalence and determinants of nasal colonization with antibiotic-resistant Staphylococcus aureus among unselected patients attending general practitioners in Germany

Epidemiology and Infection

Volumn 132, Issue 4, 2004, Pages 655-662

  Lietzau, S ^a   Sturmer T ^a   Erb, A ^a   Von Baum, H ^b   Marre, R ^b   Brenner, H ^a  

^a GERMAN CENTRE FOR RESEARCH ON AGEING   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINAFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; METICILLIN; MOXIFLOXACIN; NETILMICIN; OXACILLIN; PENICILLIN G; PENICILLINASE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; FEMALE; GENERAL PRACTITIONER; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOSE CAVITY; NOSE SMEAR; PATIENT SELECTION; PREVALENCE; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; CLINICAL TRIAL; DRUG EFFECT; GENERAL PRACTICE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; NOSE MUCOSA; QUESTIONNAIRE; STAPHYLOCOCCUS INFECTION; STATISTICS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FAMILY PRACTICE; FEMALE; GERMANY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NASAL MUCOSA; OXACILLIN; PREVALENCE; QUESTIONNAIRES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 4143091737     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/Sh0950268804002341     Document Type: Article

References (31)

1. Gold HW, Moellering RC. Antimicrobial-drug resistance. N Engl J Med 1996; 335: 1445-1453.
2. Vincent JL. Microbial resistance: lessons from the EPIC study. European prevalence of infection. Intensive Care Med 2000; 26 (Suppl 1): 3-8.
3. Pichichero ME. Dynamics of antibiotic prescribing for children. J Am Med Assoc 2002; 287: 3133-3135.
4. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. J Am Med Assoc 2002; 287: 3096-3102.
5. De Man P, Verhoeven BAN, Verbugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355: 973-978.
6. EARSS (European Antimicrobial Resistance Surveillance System). Annual report, EARSS 2001. Bilthoven, The Netherlands, 2002 (http://www.earss.rivm.nl/). Accessed August 2003.
7. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532.
8. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001; 1: 147-155.
9. Centers for Disease Control and Prevention. Vancomycin resistant Staphylococcus aureus - Pennsylvania, 2002. J Am Med Assoc 2002; 288: 2116.
10. Rosenberg J. Methicillin-resistant Staphylococcus aureus (MRSA) in the community: who's watching? Lancet 1995; 346: 132-133.
11. Boyce JM. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? J Am Med Assoc 1998; 279: 623-624.
12. Shopsin B, Mathema B, Martinez J, et al. Prevalence methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the Community. J Infect Dis 2000; 182: 359-362.
13. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34: 425-433.
14. Sa-Leao R, Sanches IS, Couto I, Alves CR, de Lencastre H. Low prevalence of methicillin-resistant strains among Staphylococcus aureus colonizing young and healthy members of the community in Portugal. Microb Drug Resist 2001; 7: 237-245.
15. Salmenlinna S, Lyytikäinen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis 2002; 8: 602-607.
16. Abudu L, Blair I, Fraise A, Cheng KK. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 2001; 126: 351-356.
17. Robert Koch Institute (RKI). Increasing incidence of methicillin-resistant Staphylococcus aureus in German hospitals [in German]. [Zunahme des Auftretens von MRSA in deutschen Krankenhäusern.] Epidemiologisches Bulletin 2000; 9: 70-71.
18. German Institute for Standardization (DIN). Medical microbiology - susceptibility testing of microbial pathogens to antimicrobial agents [Medizinische Mikrobiologie und Immunologie. E 58 940 Teil 4 (Methoden zur Empfindlichkeitsprüfung von bakteriellen Krankheitserregern (außer Mykobakterien) gegen Chemotherapeutika]. Beuth-Verlag, Berlin.
19. GENARS (German Network on Antimicrobial Resistance Surveillance). Current data, Situation of resistance, May 2000 - September 2000 (www.genars.de). Accessed March 2003.
20. Kresken M, Hafner D, Schmitz FJ, Wichelhaus T. PEG-Resistenzstudie 2001. Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. [in German] (http://www.antiinfectives-intelligence.de/ peg/ag_resistenz/peg_resistenzstudie_2001.pdf). Accessed August 2003.
21. Schwabe U, Paffrath D. Drug utilization report 2000 [in German]. [Arzneiverordnungsreport 2000.] Heidelberg, Berlin: Springer-Verlag.
22. Stürmer T, Erb A, Marre R, Brenner H. Prevalence and determinants of colonization with antibiotic resistant Escherichia coli in unselected patients attending general practitioners in Germany. Pharmacoepidemiol Drug Saf (in press).
23. Robert Koch Institute (RKI). Staphylococcus aureus infections with special consideration of MRSA [in German]. [Erkrankungen durch Staphylococcus aureus unter besonderer Berücksichtigung der MRSA.] Epidemiologisches Bulletin 2000; 8: 61-65.
24. Salgado C, Farr B, Calfee D. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and Risk factors. Clin Infect Dis 2003; 36: 131-139.
25. Hussain FM, Boyle-Vara S, Bethel CD, Daum RS. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 2000; 19: 1163-1166.
26. Suggs AH, Maranan MC, Boyle-Vara S, Daum RS. Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. Pediatr Infect Dis J 1999; 18: 410-414.
27. von Baum H, Schmidt C, Svoboda D, Bock-Hensley O, Wendt C. Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infect Control Hosp Epidemiol 2002; 23: 511-515.
28. Fraise AP, Mitchell K, O'Brien SJ, Oldfield K, Wise R. Methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes in a major UK city: an anonymized point prevalence survey. Epidemiol Infect 1997; 118: 1-5.
29. Warshawsky B, Hussain Z, Gregson D, et al. Hospital and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol 2000; 21: 724-727.
30. Morgan M, Salmon R, Keppie N, Evans-Williams D, Hosein I, Lookers DN. All Wales surveillance of methicillin-resistant Staphylococcus aureus (MRSA): the first year's result. J Hosp Infect 1999; 41: 173-179.
31. Rezende NA, Blumberg HM, Metzger BS, Larsen NM, Ray SM, McGowan JE. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci 2002; 323: 117-123.